Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and the group of Eating Disorders, of the Bellvitge University Hospital (HUB), led by Dr. Fernando Fernández-Aranda, published a study in Scientific ...
Jun 12, 2019
0
0
Every year in Catalonia 15 new cases of Creutzfeldt Jakob Disease are diagnosed. It is a deadly prion disease whose cause is unknown and has no treatment, though it is very similar to mad cow disease, also brought on by prions ...
May 29, 2019
0
0
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ProCURE program) have published the bases for new therapies against colorectal cancer in Clinical Cancer Research.
Apr 18, 2019
0
0
Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) led by Dr. Montse Olivé have described in Nature Communications a new muscular disease caused by a mutation in the myoglobin gene. The study was led by ...
Mar 27, 2019
0
36
Obsessive-compulsive disorder (OCD) is characterized by alterations in brain connectivity, i.e., patients present a dysfunction related to the synchronization of activity between different groups of neurons, as evidenced ...
Feb 28, 2019
0
0
The Neurometabolic Diseases research team at IDIBELL and CIBER of Rare Diseases (CIBERER), led by ICREA Professor Aurora Pujol, has reported a novel disease affecting myelin in children, leading to severe incapacity and death ...
Jan 10, 2019
0
0
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute (IDIBELL) and the University of Barcelona (UB), in collaboration with several hospitals, have discovered that ...
Dec 13, 2018
0
0
Prostate Cancer researchers from the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Álvaro Aytés report a new combined therapy to fight the most aggressive and resistant prostate cancers. The team, which ...
Dec 6, 2018
0
4
Researchers from the Metabolism and Cancer group at the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Sara Kozma, have unveiled a new potential combined treatment for hepatocellular carcinoma (HCC), the second ...
Jun 28, 2018
0
0
A new study by doctor Manel Esteller, Director of the Epigenetics and Cancer Biology Program (PEBC) of the Bellvitge Biomedical Research Institute (IDIBELL), ICREA Researcher and Professor of Genetics at the University of ...
Jun 12, 2018
0
6
